Evidence map›Paper›PMID 35337809›Full record

ArticleChest2022

Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.

Janet Lee, Emily White, Elizabeth Freiheit, Mary Beth Scholand, Mary E Strek, Anna J Podolanczuk, Nina M Patel, Pulmonary Fibrosis Foundation

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Chest, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Patient-reported outcome measures for cough used in interstitial lung disease: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2025
    Pooled it
  3. Article
  4. Review
  5. Article
  6. Cough and dyspnea management in pulmonary fibrosis.Current opinion in supportive and palliative care · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Cough in Fibrotic Interstitial Lung Disease: Effects and Implications.American journal of respiratory and critical care medicine · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Janet LeeSection of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT. Electronic address: janetlee423@gmail.com.
Emily WhiteDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI.
Elizabeth FreiheitDepartment of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI.
Mary Beth ScholandSection of Pulmonary and Critical Care Medicine, University of Utah, Salt Lake City, UT.
Mary E StrekSection of Pulmonary and Critical Care Medicine, University of Chicago, Chicago, IL.
Anna J PodolanczukDivision of Pulmonary and Critical Care Medicine, Weill Cornell Medical Center, New York, NY.
Nina M PatelDivision of Pulmonary, Allergy and Critical Care Medicine, Columbia University Medical Center, New York, NY; Boehringer-Inghelheim, Ridgefield, CT. Electronic address: nina.patel@boehringer-ingelheim.com.
Pulmonary Fibrosis FoundationPulmonary Fibrosis Foundation, Chicago, IL.
University of Michigan · USUniversity of Utah · USCornell University · USUniversity of Chicago · USColumbia University Irving Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCough is a common symptom of interstitial lung disease (ILD) and negatively impacts health-related quality of life (QOL). Previous studies have shown that among patients with idiopathic pulmonary fibrosis, cough may predict progression of lung disease and perhaps even respiratory hospitalizations and mortality. RESEARCH QUESTION: Does cough-specific QOL predict disease progression, respiratory hospitalization, lung transplantation, and death among patients with ILD? STUDY DESIGN AND

methodsWe analyzed data from the Pulmonary Fibrosis Foundation Registry, which comprises a multicenter population of well-characterized patients with ILD. We first examined associations between patient factors and baseline scores on the Leicester Cough Questionnaire (LCQ), a cough-specific QOL tool, using a proportional odds model. Next, we examined associations between baseline LCQ scores and patient-centered clinical outcomes, as well as pulmonary function parameters, using a univariable and multivariable proportional hazards model that was adjusted for clinically relevant variables, including measures of disease severity.

resultsOne thousand four hundred forty-seven patients with ILD were included in our study. In the multivariable proportional odds model, we found that the following patient factors were associated with worse cough-specific QOL: younger age, diagnosis of "other ILD," gastroesophageal reflux disease, and lower FVC % predicted. Multivariable Cox regression models, adjusting for several variables including baseline disease severity, showed that a 1-point decrease in LCQ score (indicating lower cough-specific QOL) was associated with a 6.5% higher risk of respiratory-related hospitalization (hazard ratio [HR], 1.065; 95% CI, 1.025-1.107), a 7.4% higher risk of death (HR, 1.074; 95% CI, 1.020-1.130), and an 8.7% higher risk of lung transplantation (HR, 1.087; 95% CI, 1.022-1.156).

interpretationAmong a large population of well-characterized patients with ILD, cough-specific QOL was associated independently with respiratory hospitalization, death, and lung transplantation.

Indexed as

Idiopathic Pulmonary FibrosisLung Diseases, InterstitialCoughDisease ProgressionHumansQuality of LifeRegistriescoughdisease progressionhealth-related quality of lifeidiopathic pulmonary fibrosisinterstitial lung diseaseLeicester cough questionnairemortality

Identifiers

PMID35337809
PMCPMC9808640
OpenAlexW4220936620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.